Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Myomo Inc (MYO)

Myomo Inc (MYO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,322
  • Shares Outstanding, K 3,672
  • Annual Sales, $ 3,840 K
  • Annual Income, $ -10,710 K
  • 60-Month Beta 1.21
  • Price/Sales 5.12
  • Price/Cash Flow N/A
  • Price/Book 1.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -1.08
  • Number of Estimates 3
  • High Estimate -0.72
  • Low Estimate -1.28
  • Prior Year -4.80
  • Growth Rate Est. (year over year) +77.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.46 +44.22%
on 09/04/20
5.67 -11.99%
on 09/16/20
+1.07 (+27.30%)
since 08/18/20
3-Month
3.46 +44.22%
on 09/04/20
5.67 -11.99%
on 09/16/20
+1.16 (+30.29%)
since 06/18/20
52-Week
2.82 +76.95%
on 03/18/20
40.00 -87.53%
on 02/05/20
-18.45 (-78.71%)
since 09/18/19

Most Recent Stories

More News
Thinking about buying stock in Myomo Inc, Parsley Energy, Fortress Biotech, AVEO Pharmaceuticals, or Nio Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MYO, PE, FBIO, AVEO, and NIO.

AVEO : 6.25 (+2.63%)
PE : 9.93 (-2.84%)
FBIO : 4.78 (+6.46%)
MYO : 4.99 (-6.73%)
NIO : 19.41 (+0.57%)
Myomo Certified as Medicare Provider

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 4.99 (-6.73%)
Myomo(R) to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 4.99 (-6.73%)
Myomo, Inc. to Present at The LD 500 Virtual Conference

LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Myomo, Inc. (NYSE American:MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders...

MYO : 4.99 (-6.73%)
Myomo(R) Extends and Strengthens its Global MyoPro(TM) Patent Portfolio

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 4.99 (-6.73%)
Myomo(R) Receives First Australian Insurance Authorization for MyoPro(TM)

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 4.99 (-6.73%)
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 14.50% and 43.17%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

MYO : 4.99 (-6.73%)
Myomo to Report Second Quarter Financial Results on August 10, 2020

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis,...

MYO : 4.99 (-6.73%)
Myomo Resumes Fitting MyoPro Patients and Deliveries as States Begin to Re-Open after COVID-19 Shutdowns

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 4.99 (-6.73%)
Myomo(R) Uses Telehealth Techniques to Conduct Safe Patient Screenings

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,...

MYO : 4.99 (-6.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade MYO with:

Business Summary

Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed...

See More

Key Turning Points

2nd Resistance Point 5.40
1st Resistance Point 5.20
Last Price 4.99
1st Support Level 4.86
2nd Support Level 4.72

See More

52-Week High 40.00
Fibonacci 61.8% 25.80
Fibonacci 50% 21.41
Fibonacci 38.2% 17.02
Last Price 4.99
52-Week Low 2.82

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar